Skip to main content

Advertisement

Table 2 Mean and median survival times for all treatment groups

From: Experimental α-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumab

Treatment Dosage Mean ± standard error Median ± standard error Number of mice
NaCl   52 ± 10 42 ± 13 10
Trastuzumab (Pooled) 20 - 250 μg 54 ± 5 47 ± 2 16
227Th-rituximab 400 kBq/kg 44 ± 5 49 ± 8 9
227Th- rituximab 600 kBq/kg 47 ± 5 36 ± 3 10
227Th-trastuzumab 200 kBq/kg 39 ± 2 38 ± 2 10
227Th-trastuzumab 400 kBq/kg 87 ± 7* 63 ± 3* 11
227Th-trastuzumab 600 kBq/kg 95 ± 3* 96 ± 3* 12
  1. *Significant difference between control and therapy.